BRCA2 and predisposition to pancreatic and other cancers

Meghan A. Arnold, Michael S Goggins

Research output: Contribution to journalArticle

Abstract

Pancreatic adenocarcinoma is a major cause of cancer deaths in the industrialised world. Recent work has focused on the genetics of pancreatic cancer with a goal of finding an early detection marker that might allow for greater rates of survival than are currently possible. The breast cancer 2 gene (BRCA2) is one of numerous genes implicated in familial pancreatic cancer. Carriers of germline mutations of the BRCA2 gene have an increased risk of several cancers, among them pancreatic adenocarcinoma. During pancreatic carcinogenesis, bi-allelic inactivation of BRCA2 occurs as a late event, suggesting that other genetic events must occur before neoplastic cells can tolerate loss of BRCA2.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalExpert Reviews in Molecular Medicine
Volume3
Issue number14
DOIs
StatePublished - May 14 2001

    Fingerprint

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Cite this